TrialThe American journal of psychiatry2008
Initial phase 2 trial of a nicotinic agonist in schizophrenia.
Robert Freedman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
194 papers cite itlatest 60 shown
this paperpooled ittrialcites it